방충제 유효 성분 시장 - 세계 예측(2026-2032년)

The Insect Repellent Active Ingredients Market is projected to grow by USD 1.98 billion at a CAGR of 8.97% by 2032.

Insect repellent active ingredients are becoming increasingly important in public health, outdoor recreation, travel medicine, agriculture-adjacent environments, and household protection as vector-borne diseases expand in geographic range and consumer demand rises for safer, longer-lasting, and more pleasant formulations. Core actives such as DEET, picaridin, IR3535, permethrin for treated fabrics, p-menthane-3,8-diol, and botanical oil-derived ingredients are evaluated through the combined lens of efficacy, toxicology, skin compatibility, odor profile, environmental fate, and regulatory acceptance. The industry is shaped by the need to protect against mosquitoes, ticks, flies, fleas, and other biting insects associated with diseases including malaria, dengue, Zika, chikungunya, West Nile virus, Lyme disease, and Japanese encephalitis. Climate variability, urbanization, increased international mobility, and changing land-use patterns are intensifying exposure risks, making evidence-based insect repellent active ingredient selection central to both consumer products and institutional prevention programs. In this environment, manufacturers, formulators, public agencies, and procurement teams are prioritizing active ingredients with proven performance, clear labeling, compatibility with diverse application formats, and alignment with evolving safety and sustainability expectations.

Transformative Shifts in the Landscape

The insect repellent active ingredients landscape is undergoing a significant transformation as stakeholders move beyond basic bite prevention toward integrated protection, user compliance, and environmental responsibility. Regulatory scrutiny is increasing around product claims, exposure limits, children's use, and ecological impact, requiring stronger data packages and transparent ingredient communication. At the same time, consumers are seeking products that are effective yet comfortable to wear, non-greasy, low-odor, fabric-safe, and suitable for repeated use in humid, tropical, and outdoor settings. This shift is driving innovation in controlled-release technologies, microencapsulation, water-resistant formulations, wearable formats, and hybrid approaches that combine synthetic and nature-derived actives while maintaining validated efficacy. Public health priorities are also influencing demand, as mosquito and tick ranges shift into new areas and authorities emphasize personal protective measures alongside vector control. The result is a more sophisticated market environment in which efficacy alone is no longer sufficient; active ingredients must also support compliance, safety assurance, differentiated sensory performance, and credible sustainability narratives.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across the insect repellent active ingredients ecosystem by accelerating discovery, formulation design, toxicological screening, supply chain intelligence, and regulatory readiness. Machine learning models can help identify candidate molecules with repellent potential by analyzing structure-activity relationships, volatility, odor characteristics, persistence on skin, and predicted interaction with insect olfactory receptors. In formulation development, AI-assisted modeling supports optimization of active concentration, solvent systems, fixatives, emulsifiers, and release profiles, reducing iterative lab cycles while improving stability and consumer acceptability. AI can also strengthen safety assessment by flagging potential irritancy, sensitization, environmental persistence, and exposure risks earlier in development. In manufacturing and procurement, predictive analytics can monitor raw material availability, detect supply disruptions, and support quality control for botanical extracts whose composition may vary by origin, harvest, and processing conditions. For commercial teams, AI-enabled social listening and search trend analysis help identify emerging consumer concerns around ticks, dengue outbreaks, children's repellents, natural claims, and travel protection. The cumulative impact is a more responsive and evidence-led innovation pipeline, provided organizations maintain strong validation protocols, human scientific oversight, and compliance with regulatory standards.

Key Regional Insights

Asia-Pacific represents one of the most dynamic regions for insect repellent active ingredients due to high exposure to mosquito-borne diseases, dense urban environments, monsoon-driven vector activity, and rising consumer adoption of personal protection products. Countries across South and Southeast Asia face recurring dengue and malaria risks, making efficacy against Aedes and Anopheles mosquitoes a major formulation priority. North America is shaped by growing awareness of tick-borne diseases, including Lyme disease, along with mosquito-related risks such as West Nile virus, which supports demand for actives with strong performance in outdoor, camping, sports, and family-use applications. Latin America continues to prioritize protection against dengue, Zika, chikungunya, and other arboviral threats, with tropical and subtropical climates supporting sustained mosquito pressure and a need for affordable, accessible, and heat-stable formulations. Europe is influenced by stringent chemical regulation, increasing tick exposure in forested and peri-urban areas, and consumer interest in lower-odor and dermatologically acceptable products. The Middle East has demand shaped by travel, pilgrimage, desert and oasis ecologies, and imported vector-borne disease prevention needs, while Africa remains closely linked to malaria prevention, humanitarian procurement, and public health campaigns where proven efficacy, cost-effectiveness, and usability in high-temperature conditions are critical.

Key Group Insights

ASEAN countries are central to the insect repellent active ingredients discussion because tropical climates, high dengue incidence, rapid urbanization, and outdoor work patterns support continuous need for mosquito protection across household, travel, and institutional channels. GCC countries emphasize repellents for residents, expatriate workers, travelers, and mass gathering contexts, with product performance under heat, sweat, and outdoor exposure conditions playing an important role. The European Union has a major influence on ingredient standards through rigorous biocidal product evaluation, labeling requirements, and consumer safety expectations, encouraging active ingredient suppliers and formulators to maintain strong compliance documentation. BRICS economies combine large populations, diverse climatic zones, manufacturing capability, and substantial public health priorities, creating varied demand across urban consumer products, rural disease prevention, and export-oriented formulation development. G7 countries are important for regulatory science, toxicology standards, premium product innovation, and consumer preference shifts toward effective yet aesthetically acceptable repellents. NATO member countries add a specialized dimension through military, field deployment, and emergency preparedness needs, where insect repellent active ingredients must perform reliably in rugged environments, integrate with treated uniforms or gear, and support protection against vectors encountered during international operations.

Key Country Insights

The United States has strong demand for insect repellent active ingredients driven by mosquito and tick exposure, outdoor recreation, travel health guidance, and regulatory emphasis on substantiated claims, with DEET, picaridin, oil of lemon eucalyptus-derived actives, IR3535, and permethrin-treated clothing all playing recognized roles. Canada shares many tick-related concerns, particularly in warmer seasons and wooded environments, while also requiring products suited to family, camping, and wilderness use. Mexico and Brazil face significant mosquito-borne disease pressures, especially dengue and other arboviruses, making accessible and durable mosquito repellency a key requirement in urban and tropical settings. The United Kingdom, Germany, France, Italy, and Spain are shaped by tick prevention, travel-related mosquito protection, and high regulatory expectations for safety and labeling, while warmer Southern European conditions and invasive mosquito species increase the relevance of Aedes-focused repellency. Russia's diverse geography creates seasonal demand linked to mosquitoes and ticks, particularly in forested and rural areas. China and India represent high-priority countries due to large populations, urban mosquito exposure, dengue activity in multiple regions, and broad demand for household and personal protection formats. Japan emphasizes high-quality, convenient, and low-odor repellents suited to urban consumers and outdoor activities, while Australia requires strong protection against mosquitoes in tropical and coastal areas and ticks in specific regions. South Korea combines seasonal mosquito exposure, outdoor recreation, and consumer preference for convenient formats, supporting continued interest in proven and comfortable active ingredient systems.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize active ingredient portfolios that combine proven efficacy, strong safety documentation, and adaptability across sprays, lotions, wipes, aerosols, roll-ons, creams, wearable formats, and treated textiles. Formulators should invest in sensory improvement, longer-lasting protection, and water- or sweat-resistant delivery systems without compromising regulatory compliance or user safety. Regulatory teams should maintain robust data packages covering efficacy testing, toxicology, exposure assessment, environmental fate, label claims, and jurisdiction-specific requirements. Procurement leaders should diversify sourcing for both synthetic and botanical actives, especially where climate, harvest variability, or geopolitical disruptions may affect availability and quality consistency. Product teams should tailor claims and formats to regional vector risks, such as tick-focused messaging in temperate regions and mosquito-focused protection in dengue- and malaria-prone regions. Scientific and commercial teams should work closely with public health guidance, travel medicine recommendations, and consumer education initiatives to improve correct usage, reapplication behavior, and trust. Leaders should also evaluate AI-enabled discovery, formulation modeling, and quality analytics while ensuring that all outputs are validated through recognized laboratory and field testing protocols.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified and data-backed sources relevant to insect repellent active ingredients, vector-borne disease prevention, regulatory science, and formulation trends. The research framework considers public health agency guidance, regulatory documentation, peer-reviewed scientific literature, toxicology and efficacy evaluation principles, product labeling standards, and region-specific vector exposure patterns. Key variables assessed include active ingredient efficacy against mosquitoes and ticks, duration of protection, safety profile, user compliance factors, climatic suitability, formulation compatibility, environmental considerations, and regulatory acceptance across major jurisdictions. Regional, group, and country insights are synthesized by correlating documented vector-borne disease risks, public health priorities, climate-driven exposure patterns, consumer behavior, and policy environments. The methodology deliberately avoids market estimation, market sizing, market share, and forecasting, focusing instead on qualitative and evidence-based interpretation of industry dynamics, technology shifts, and strategic implications for stakeholders.

Conclusion

The insect repellent active ingredients landscape is increasingly defined by the intersection of public health urgency, consumer experience, regulatory accountability, and science-led innovation. As mosquitoes and ticks expand into new environments and disease prevention remains a priority across tropical, temperate, urban, rural, and travel settings, demand is shifting toward active ingredients and formulations that deliver reliable protection while supporting safety, comfort, and compliance. Synthetic actives with established performance continue to be essential, while nature-derived and hybrid systems are gaining attention when supported by credible efficacy and safety evidence. Artificial intelligence, advanced formulation science, and stronger quality analytics are expected to improve the speed and precision of ingredient development, but validated testing and regulatory discipline remain indispensable. Organizations that align active ingredient strategy with regional vector risks, user needs, supply resilience, and transparent claims will be best positioned to support effective personal protection and long-term category relevance.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Insect Repellent Active Ingredients Market, by Active Ingredient

• 7.1. Introduction
• 7.2. Deet
• 7.3. Oil Of Lemon Eucalyptus
• 7.4. Permethrin
• 7.5. Picaridin

8. Insect Repellent Active Ingredients Market, by Form

• 8.1. Introduction
• 8.2. Aerosol
• 8.3. Cream
• 8.4. Gel
• 8.5. Lotion
• 8.6. Spray
• 8.7. Wipe

9. Insect Repellent Active Ingredients Market, by Application

• 9.1. Introduction
• 9.2. Clothing Treatment
• 9.3. Spatial Repellents
• 9.4. Topical Application
  • 9.4.1. Topical Cream
  • 9.4.2. Topical Gel
  • 9.4.3. Topical Lotion
  • 9.4.4. Topical Spray
  • 9.4.5. Topical Wipe

10. Insect Repellent Active Ingredients Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Online
• 10.3. Offline

11. Insect Repellent Active Ingredients Market, by End User

• 11.1. Introduction
• 11.2. Agriculture
• 11.3. Commercial
• 11.4. Institutional
• 11.5. Residential

12. Insect Repellent Active Ingredients Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Insect Repellent Active Ingredients Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Insect Repellent Active Ingredients Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. FPNV Positioning Matrix, 2025
• 15.3. Market Concentration Analysis, 2025
  • 15.3.1. Concentration Ratio (CR)
  • 15.3.2. Herfindahl Hirschman Index (HHI)
• 15.4. Recent Developments & Impact Analysis, 2025
• 15.5. Product Portfolio Analysis, 2025
• 15.6. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Ashland Inc.
• 16.2. BASF SE
• 16.3. Central Garden & Pet Company.
• 16.4. Citrefine International Ltd.
• 16.5. Clariant AG
• 16.6. Coromandel International Limited
• 16.7. Corteva Agriscience
• 16.8. DuPont de Nemours, Inc.
• 16.9. Eastman Chemical Company
• 16.10. FMC Corporation
• 16.11. Jiangsu Panoxi Chemical Co. Ltd
• 16.12. Koninklijke DSM N.V.
• 16.13. Lanxess AG
• 16.14. Merck KGaA
• 16.15. Mitsui Chemicals Crop & Life Solutions, Inc.
• 16.16. Nissan Chemical Corporation
• 16.17. Nufarm Ltd
• 16.18. Qingdao Benzo New Materials CoLtd.
• 16.19. Reckitt Benckiser Group PLC
• 16.20. S.C. Johnson & Son Inc.
• 16.21. Sawyer Products, Inc.
• 16.22. Sharda Cropchem Limited
• 16.23. Shogun Organics Ltd.
• 16.24. Spectrum Brand Holdings Inc.
• 16.25. Sumitomo Chemical Co., Ltd.
• 16.26. Syngenta AG
• 16.27. UPL Ltd.